Healthcare & Life Sciences

Genome Biologics

Germany
Sign in to unlock

About

Genome Biologics develops therapeutic targets and discovers drugs for cardiovascular and cardiometabolic diseases using integrated technology platforms to accelerate novel therapy development for conditions with limited or no existing treatments.

Explore Genome Biologics's full profile on Brouky

Funding rounds, investor list, and risk signals — unlock with a subscription.

Sign in to unlockView pricing